Supply Chain Business Continuity

RISK MANAGEMENT

Supply Chain

Assess your risks and minimize downtime if disaster strikes.

Plan for an uninterrupted business plan

What would happen to your business if a key shipment were delayed? Or a fire destroyed your biggest supplier of materials?

The risks are real, and Lockton’s Business Continuity experts will help you assess them. Then we’ll establish contingencies to minimize downtime so that the answer is “yes” – your business will survive if disaster strikes.

Business Continuity Planning (BCP) ensures the continuation of operations in the event of a catastrophic event.  Through Lockton’s BCP disaster recovery planning, we will work with you to identify the actions, resources, and procedures that will help keep your business operational despite unexpected interruptions.

Deep analysis of your business risks and interruptions

In addition to a disaster recovery plan, Lockton’s experts will help you conduct a thorough review of your supply chain – starting by identifying the products and services that are essential to your business. We will:

  • Evaluate potential threats to essential services, then establish a Recovery Time Objective (RTO) for each essential service.

  • Play “what if?” to develop plan contingencies.

  • Appoint an executive-level team to develop a corporate global plan, including a method to update risk assessment and contingency plans.

Latest news & insights

As geopolitical conflict escalates, our recent webinar breaks down what wartime cyber activity really looks like, and what organizations should be doing now to stay resilient.Webinar | Cyber Risk in Wartime: What Leaders Need to Know Now

FTC settlement with Express Scripts signals major shift in PBM pricing

The Federal Trade Commission’s recent settlement with Express Scripts (ESI) marks one of the most significant regulatory interventions in the pharmacy benefit manager (PBM) space in years. For employers, the agreement may signal a broader shift in the industry toward true net-cost drug pricing models, with potential implications for pharmacy benefit design, budgeting, and future PBM contracting. The Federal Trade Commission’s recent settlement with Express Scripts (ESI) marks one of the most significant regulatory interventions in the pharmacy benefit manager (PBM) space in years. For employers, the agreement may signal a broader shift in the industry toward true net-cost drug pricing models, with potential implications for pharmacy benefit design, budgeting, and future PBM contracting.

First quarter state law overview: Continued litigation, enforcement activity and other updates

This state law update highlights key legal and regulatory developments affecting employee benefits and healthcare access. 
During the first quarter of the year, regulators and enforcement authorities continued to shape the benefits landscape primarily through ongoing litigation and targeted regulatory actions rather than new, sweeping legislation. This state law update highlights key legal and regulatory developments affecting employee benefits and healthcare access. 
During the first quarter of the year, regulators and enforcement authorities continued to shape the benefits landscape primarily through ongoing litigation and targeted regulatory actions rather than new, sweeping legislation.

Upcoming key compliance deadlines & reminders for second quarter 2026

The second quarter of 2026 brings a few employee benefits compliance deadlines that plan sponsors should note and prepare for in advance. This alert highlights key filing, notice, contribution, and reporting obligations commonly applicable during the April-June timeframe, including ERISA plan filings, health plan reporting, and HSA-related actions.The second quarter of 2026 brings a few employee benefits compliance deadlines that plan sponsors should note and prepare for in advance. This alert highlights key filing, notice, contribution, and reporting obligations commonly applicable during the April-June timeframe, including ERISA plan filings, health plan reporting, and HSA-related actions.
View All news and insights